ES2181444T3 - Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. - Google Patents
Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias.Info
- Publication number
- ES2181444T3 ES2181444T3 ES99924991T ES99924991T ES2181444T3 ES 2181444 T3 ES2181444 T3 ES 2181444T3 ES 99924991 T ES99924991 T ES 99924991T ES 99924991 T ES99924991 T ES 99924991T ES 2181444 T3 ES2181444 T3 ES 2181444T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- tumor
- production
- neoplasias
- induction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Vacuna, que comprende un bacteriófago o un fragmento funcional equivalente del mismo, el cual expresa por lo menos, un antígeno específico de un tumor y/o un antígeno asociado a un tumor, con una longitud por lo menos de 20 aminoácidos, como proteína de fusión con una proteína de la envoltura del fago cpVIII ó un fragmento o un derivado funcional equivalente del mismo, sobre su superficie, y eventualmente contiene un soporte farmacéuticamente aceptable y/o un diluyente farmacéuticamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19821925A DE19821925A1 (de) | 1998-05-15 | 1998-05-15 | Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien |
EP9903353 | 1999-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2181444T3 true ES2181444T3 (es) | 2003-02-16 |
Family
ID=7867943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99924991T Expired - Lifetime ES2181444T3 (es) | 1998-05-15 | 1999-05-17 | Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1214942A3 (es) |
AT (1) | ATE222772T1 (es) |
AU (1) | AU764390B2 (es) |
CA (1) | CA2328057A1 (es) |
DE (2) | DE19821925A1 (es) |
DK (1) | DK1077720T3 (es) |
ES (1) | ES2181444T3 (es) |
IL (1) | IL139683A0 (es) |
WO (1) | WO1999059624A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003293958A1 (en) * | 2002-12-23 | 2004-07-22 | Apalexo Biotechnologie Gmbh | Purification of recombinant filamental bacteriophages by means of affinity chromatography to increase the immunogenicity and efficacy of phagic vaccines |
CN114907472A (zh) * | 2022-04-07 | 2022-08-16 | 武汉爱博泰克生物科技有限公司 | 一种精准复制抗体的方法及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219192A (en) * | 1986-02-07 | 1991-10-25 | Oncogen | Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines |
US5262177A (en) * | 1986-02-07 | 1993-11-16 | Oncogen | Recombinant viruses encoding the human melanoma-associated antigen |
GB9022190D0 (en) * | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
US5674486A (en) * | 1991-06-25 | 1997-10-07 | San Diego Regional Cancer Center | Cancer immunotherapy with carrier cells |
US5759535A (en) * | 1994-05-13 | 1998-06-02 | Research Corporation Technologies, Inc. | Immunotherapeutic strategies for the treatment of cancer |
-
1998
- 1998-05-15 DE DE19821925A patent/DE19821925A1/de not_active Ceased
-
1999
- 1999-05-17 ES ES99924991T patent/ES2181444T3/es not_active Expired - Lifetime
- 1999-05-17 AU AU41442/99A patent/AU764390B2/en not_active Ceased
- 1999-05-17 AT AT99924991T patent/ATE222772T1/de not_active IP Right Cessation
- 1999-05-17 IL IL13968399A patent/IL139683A0/xx unknown
- 1999-05-17 CA CA002328057A patent/CA2328057A1/en not_active Abandoned
- 1999-05-17 DK DK99924991T patent/DK1077720T3/da active
- 1999-05-17 EP EP02003333A patent/EP1214942A3/de not_active Withdrawn
- 1999-05-17 DE DE59902472T patent/DE59902472D1/de not_active Expired - Fee Related
- 1999-05-17 WO PCT/EP1999/003380 patent/WO1999059624A2/de active IP Right Grant
- 1999-05-17 EP EP99924991A patent/EP1077720B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK1077720T3 (da) | 2004-03-22 |
ATE222772T1 (de) | 2002-09-15 |
AU764390B2 (en) | 2003-08-14 |
CA2328057A1 (en) | 1999-11-25 |
DE19821925A1 (de) | 1999-11-18 |
EP1214942A2 (de) | 2002-06-19 |
DE59902472D1 (de) | 2002-10-02 |
EP1077720B1 (de) | 2002-08-28 |
EP1077720A2 (de) | 2001-02-28 |
AU4144299A (en) | 1999-12-06 |
WO1999059624A2 (de) | 1999-11-25 |
EP1214942A3 (de) | 2002-10-02 |
WO1999059624A3 (de) | 2000-01-27 |
IL139683A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE328095T1 (de) | Verbesserungen des stärkegehaltes von pflanzen | |
NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
ATE293690T1 (de) | Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie | |
BRPI0507579A (pt) | molécula de ácido nucleico, vetor, célula hospedeira, processo para expressar uma proteìna de fusão cea em uma célula hospedeira recombinante, proteìna de fusão cea purificada, método de prevenção ou tratamento de cáncer, plasmìdeo de vacina, e, método de tratamento de um mamìfero sofrendo de ou predisposto a um cáncer associados com cea | |
EP0681585A4 (en) | FACTORS ASSOCIATED TO TATA-BINDING PROTEINS, NUCLEIC ACIDS ENCODING TAFS AND METHODS FOR USE THEREOF. | |
EP1214098A4 (en) | CAPSIDE-MODIFIED RECOMBINANT ADENOVIRUS AND METHOD FOR USE THEREOF | |
WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
HK1049185A1 (zh) | 可改螢光蛋白 | |
ES2141249T3 (es) | Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
ATE309356T1 (de) | Konstruierte fluoreszenzproteine mit langen wellenlängen | |
ES2181444T3 (es) | Composicion para la induccion de una respuesta inmunologica especifica de un tumor, metodo para la produccion y utilizacion de dicha composicion en el tratamiento de neoplasias. | |
DE59712554D1 (de) | Rekombinante expression von s-layer-proteinen | |
HUP9901786A2 (hu) | Eljárás helypreferált rákos áttétképződéssel kapcsolatos gének azonosítására immuno-mágneses sejtszeparáció felhasználásával | |
DE3882455D1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. | |
EP0888374A4 (en) | NUCLEIC ACID LIGANDS WITH HIGH AFFINITY FOR THE PROTEINS OF THE COMPLEMENT SYSTEM | |
PT870015E (pt) | Novas xilanases os genes que as codificam e as suas utilizacoes | |
WO2000053785A3 (en) | Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins | |
ATE327334T1 (de) | Atp- und nukleinsäure-bindendes protein mit helikase- und atpase eigenschaften | |
DE60134956D1 (de) | Gene differentiell experimiert in brudtkrebs | |
WO2002006340A3 (en) | Tetraspan protein and uses thereof | |
DK1214453T3 (da) | Hidtil ukendte cellecykluskontrolpunktgener og proteiner kodet deraf | |
CA2347371A1 (en) | HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE | |
BR9810643A (pt) | Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos | |
MXPA01010890A (es) | Acidos nucleicos aislados de la familia p-hyde, proteinas p-hyde, y metodos para inducir susceptibilidad a la induccion de muerte celular en cancer. |